Bade BC and Dela Cruz CS: Lung cancer 2020: Epidemiology, etiology, and prevention. Clin Chest Med. 41:1–24. 2020.PubMed/NCBI View Article : Google Scholar

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar

Spiro SG and Silvestri GA: One hundred years of lung cancer. Am J Respir Crit Care Med. 172:523–529. 2005.PubMed/NCBI View Article : Google Scholar

Rébé C and Ghiringhelli F: Cytotoxic effects of chemotherapy on cancer and immune cells: How can it be modulated to generate novel therapeutic strategies? Future Oncol. 11:2645–2654. 2015.PubMed/NCBI View Article : Google Scholar

Su CY, Ming QL, Rahman K, Han T and Qin LP: Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 13:163–182. 2015.PubMed/NCBI View Article : Google Scholar

Zhang JP, Zhang YY, Zhang Y, Gao YG, Ma JJ, Wang N, Wang JY, Xie Y, Zhang FH and Chu L: Salvia miltiorrhiza (Danshen) injection ameliorates iron overload-induced cardiac damage in mice. Planta Med. 79:744–752. 2013.PubMed/NCBI View Article : Google Scholar

Xiong XJ, Wang Z and Wang J: Innovative strategy in treating angina pectoris with Chinese patent medicines by promoting blood circulation and removing blood stasis: Experience from combination therapy in Chinese medicine. Curr Vasc Pharmacol. 13:540–553. 2015.PubMed/NCBI View Article : Google Scholar

Tawil N and Rak J: Blood coagulation and cancer genes. Best Pract Res Clin Haematol. 35(101349)2022.PubMed/NCBI View Article : Google Scholar

Qi Y: Progress of modern research on tumor blood stasis syndrome and its treatment with the method of promoting blood circulation by removing blood stasis. J Tradit Chin Med. 15:68–76. 1995.PubMed/NCBI

Li ZM, Xu SW and Liu PQ: Salvia miltiorrhiza Burge (Danshen): A golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 39:802–824. 2018.PubMed/NCBI View Article : Google Scholar

Liang WY, Chen WJ, Yang GH, Zhu D, Mao X, Shao YY, Wu LF, Zhang XX and Zhang LZ: Research progress on salvianolic acids of Salvia miltiorrhiza. Zhongguo Zhong Yao Za Zhi. 41:806–812. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Wang J, Xu J, Gong X, Yang M, Zhang C and Li M: Biosynthesis, chemistry, and pharmacology of polyphenols from Chinese Salvia species: A review. Molecules. 24(155)2019.PubMed/NCBI View Article : Google Scholar

Pang H, Wu L, Tang Y, Zhou G, Qu C and Duan JA: Chemical analysis of the herbal medicine Salviae miltiorrhizae Radix et Rhizoma (Danshen). Molecules. 21(51)2016.PubMed/NCBI View Article : Google Scholar

Guo R, Li L, Su J, Li S, Duncan SE, Liu Z and Fan G: Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Des Devel Ther. 14:4735–4748. 2020.PubMed/NCBI View Article : Google Scholar

Liu MZ, Huang YS and Xiao WQ: No promoting effects of sodium tanshinone II-A sulfonate on growth and metastasis of Lewis carcinoma. Zhongguo Yao Li Xue Bao. 12:534–537. 1991.PubMed/NCBI(In Chinese).

Zhou J, Jiang YY, Chen H, Wu YC and Zhang L: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 53(e12739)2020.PubMed/NCBI View Article : Google Scholar

Yin ZK, Liu ZZ, Yuan X, Feng ZM, Jiang JS, Zhang X, Zhang PC and Yang YN: Thirteen undescribed diterpenoid quinones derived from the rhizomes of Salvia miltiorrhiza and their anti-tumor activities. Phytochemistry. 191(112902)2021.PubMed/NCBI View Article : Google Scholar

Wang Y and Zhang D: Tanshinol inhibits growth of malignant melanoma cells via regulating miR-1207-5p/CHPF pathway. Arch Dermatol Res. 312:373–383. 2020.PubMed/NCBI View Article : Google Scholar

Ye YT, Zhong W, Sun P, Wang D, Wang C, Hu LM and Qian JQ: Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. J Ethnopharmacol. 200:107–116. 2017.PubMed/NCBI View Article : Google Scholar

Chen X, Guo J, Bao J, Lu J and Wang Y: The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): A systematic review. Med Res Rev. 34:768–794. 2014.PubMed/NCBI View Article : Google Scholar

Qian W, Wang Z, Xu T and Li D: Anti-apoptotic effects and mechanisms of salvianolic acid A on cardiomyocytes in ischemia-reperfusion injury. Histol Histopathol. 34:223–231. 2019.PubMed/NCBI View Article : Google Scholar

Tang SM, Xing XY, Deng XH, Zhao NN, Li G, Yang RC, Sun GB and Sun XB: Research progress of Guanxin Danshen formula and its effective components in treating coronary artery heart disease. Zhongguo Zhong Yao Za Zhi. 41:3721–3726. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Ren J, Fu L, Nile SH, Zhang J and Kai G: Salvia miltiorrhiza in treating cardiovascular diseases: A review on its pharmacological and clinical applications. Front Pharmacol. 10(753)2019.PubMed/NCBI View Article : Google Scholar

Shi MJ, Yan XL, Dong BS, Yang WN, Su SB and Zhang H: A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis. J Ethnopharmacol. 253(112689)2020.PubMed/NCBI View Article : Google Scholar

Tang YX, Liu M, Liu L, Zhen BR, Wang TT, Li N, Lv N, Zhu Z, Sun G, Wang X and Chen S: Lipophilic constituents in Salvia miltiorrhiza Inhibit activation of the hepatic stellate cells by suppressing the JAK1/STAT3 signaling pathway: A network pharmacology study and experimental validation. Front Pharmacol. 13(770344)2022.PubMed/NCBI View Article : Google Scholar

Tseng YJ, Hung YC, Kuo CE, Chung CJ, Hsu CY, Muo CH, Hsu SF and Hu WL: Prescription of #adix Salvia miltiorrhiza in Taiwan: A population-based study using the national health insurance research database. Front Pharmacol. 12(719519)2021.PubMed/NCBI View Article : Google Scholar

Lee SR, Jeon H, Kwon JE, Suh H, Kim BH, Yun MK, Lim YJ and Kang SC: Anti-osteoporotic effects of Salvia miltiorrhiza Bunge EtOH extract both in ovariectomized and naturally menopausal mouse models. J Ethnopharmacol. 258(112874)2020.PubMed/NCBI View Article : Google Scholar

Chen J and Wang Y, Wang S, Zhao X, Zhao L and Wang Y: Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling. J Ethnopharmacol. 283(114667)2022.PubMed/NCBI View Article : Google Scholar

Xu X, Xu H, Shang Y, Zhu R, Hong X, Song Z and Yang Z: Development of the general chapters of the Chinese Pharmacopoeia 2020 edition: A review. J Pharm Anal. 11:398–404. 2021.PubMed/NCBI View Article : Google Scholar

Nie JM and Li HF: Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study. Exp Ther Med. 16:3405–3412. 2018.PubMed/NCBI View Article : Google Scholar

Wang H, Kang Y, Li H, Huang S, Li W, Zheng M, Huang R, Lei B and Yang X: Salvia miltiorrhiza Derived carbon dots and their heat stress tolerance of Italian lettuce by promoting growth and enhancing antioxidant enzyme activity. ACS Omega. 6:32262–32269. 2021.PubMed/NCBI View Article : Google Scholar

Duan ZZ, Li YH, Li YY, Fan GW, Chang YX, Yu B and Gao XM: Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H₂O₂-induced injury by inhibiting mitochondrial permeability transition pore opening. J Ethnopharmacol. 175:617–625. 2015.PubMed/NCBI View Article : Google Scholar

Li L, Sha Z, Wang Y, Yang D, Li J, Duan Z, Wang H and Li Y: Pre-treatment with a combination of Shenmai and Danshen injection protects cardiomyocytes against hypoxia/reoxygenation- and H₂O₂-induced injury by inhibiting mitochondrial permeability transition pore opening. Exp Ther Med. 17:4643–4652. 2019.PubMed/NCBI View Article : Google Scholar

Wang Y, Shi Y, Zou J, Zhang X, Liang Y, Tai J, Cui C, Wang M and Guo D: Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L. BMC Complement Med Ther. 20(351)2020.PubMed/NCBI View Article : Google Scholar

Jin Y, Yu L, Xu F, Zhou J, Xiong B, Tang Y, Li X, Liu L and Jin W: Pharmacokinetics of active ingredients of Salvia miltiorrhiza and Carthamus tinctorius in compatibility in normal and cerebral ischemia rats: A comparative study. Eur J Drug Metab Pharmacokinet. 45:273–284. 2020.PubMed/NCBI View Article : Google Scholar

Sun G, Li X, Wei J, Zhang T, Li B, Chen M, Wang Y, Chen K and Li Y: Pharmacodynamic substances in Salvia miltiorrhiza for prevention and treatment of hyperlipidemia and coronary heart disease based on lipidomics technology and network pharmacology analysis. Biomed Pharmacother. 141(111846)2021.PubMed/NCBI View Article : Google Scholar

Zhang Y, Wang J, Liu YM, Chen YY, Yang XC and Duan L: The synergistic effects of astragalus mongholicus and Salvia miltiorrhiza on coronary heart disease identified by network pharmacology and experiment. Drug Des Devel Ther. 15:4053–4069. 2021.PubMed/NCBI View Article : Google Scholar

Subedi L and Gaire BP: Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res. 169(105661)2021.PubMed/NCBI View Article : Google Scholar

Chong CM, Su H, Lu JJ and Wang Y: The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer's disease. Chin Med. 14(19)2019.PubMed/NCBI View Article : Google Scholar

Guo Y, Li Y, Xue L, Severino RP, Gao S, Niu J, Qin LP, Zhang D and Brömme D: Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. J Ethnopharmacol. 155:1401–1416. 2014.PubMed/NCBI View Article : Google Scholar

Guo Y, Dong X, Zhang R, Zhong Y, Yang P and Zhang SY: Salvia miltiorrhiza improves Alzheimer's disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 99(e21924)2020.PubMed/NCBI View Article : Google Scholar

Liu L and Zhang HQ: Effects of Danshen Decoction on experimental gastric ulcer in rats and mice. Zhong Xi Yi Jie He Xue Bao. 3:35–38. 2005.PubMed/NCBI View Article : Google Scholar : (In Chinese).

He S, Yang Y, Liu X, Huang W and Zhang X, Yang S and Zhang X: Compound astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. Br J Dermatol. 166:564–574. 2012.PubMed/NCBI View Article : Google Scholar

Zhang W, Li J, Yang P, Wang G, Yue Y, Zhong Y, Liu H, Gui D, Xu Y and Wang N: Efficacy and safety of Salvia miltiorrhiza for treating chronic kidney diseases: A systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022(2117433)2022.PubMed/NCBI View Article : Google Scholar

Ahn YM, Kim SK, Lee SH, Ahn SY, Kang SW, Chung JH, Kim SD and Lee BC: Renoprotective effect of tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease. Phytother Res. 24:1886–1892. 2010.PubMed/NCBI View Article : Google Scholar

Cao T, Lu Y, Zhu M, Cheng J, Ye B, Fang N, Cui Y, Xue B, Lari Najafi M and Kazemi E: Effects of Salvia miltiorrhiza and Radix astragali on the TGF-β/Smad/Wnt pathway and the pathological process of liver fibrosis in rats. Cell Mol Biol (Noisy-le-grand). 66:46–51. 2020.PubMed/NCBI

Shi M, Huang F, Deng C, Wang Y and Kai G: Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza. Crit Rev Food Sci Nutr. 59:953–964. 2019.PubMed/NCBI View Article : Google Scholar

Du G, Song J, Du L, Zhang L, Qiang G, Wang S, Yang X and Fang L: Chemical and pharmacological research on the polyphenol acids isolated from Danshen: A review of salvianolic acids. Adv Pharmacol. 87:1–41. 2020.PubMed/NCBI View Article : Google Scholar

Xu H, Li Y, Che X, Tian H, Fan H and Liu K: Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites. Drug Metab Dispos. 42:274–281. 2014.PubMed/NCBI View Article : Google Scholar

Jin YM, Tao XM, Shi YN, Lu Y and Mei JY: Salvianolic acid B exerts a protective effect in acute liver injury by regulating the Nrf2/HO-1 signaling pathway. Can J Physiol Pharmacol. 98:162–168. 2020.PubMed/NCBI View Article : Google Scholar

Jiang Z, Gao W and Huang L: Tanshinones, critical pharmacological components in Salvia miltiorrhiza. Front Pharmacol. 10(202)2019.PubMed/NCBI View Article : Google Scholar

Shahzadi I, Ali Z, Bukhari S, Narula AS, Mirza B and Mohammadinejad R: Possible applications of salvianolic acid B against different cancers. Explor Target Antitumor Ther. 1:218–238. 2020.PubMed/NCBI View Article : Google Scholar

Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G, Zhang N, Li Z, Tian X, Xu W, et al: Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep. 5(16013)2015.PubMed/NCBI View Article : Google Scholar

Raudenská M, Navrátil J, Gumulec J and Masařík M: Mechanobiology of cancerogenesis. Klin Onkol. 34:202–210. 2021.PubMed/NCBI View Article : Google Scholar

Chen L, Wang HJ, Xie W, Yao Y, Zhang YS and Wang H: Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo. Mol Med Rep. 9:2447–2452. 2014.PubMed/NCBI View Article : Google Scholar

Li Y, Gong Y, Li L, Abdolmaleky HM and Zhou JR: Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function. Mol Carcinog. 52:535–543. 2013.PubMed/NCBI View Article : Google Scholar

Chiu TL and Su CC: Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med. 25:231–236. 2010.PubMed/NCBI

Han G, Wang Y, Liu T, Gao J, Duan F, Chen M, Yang Y and Wu C: Salvianolic acid B acts against non-small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways. Mol Med Rep. 25(184)2022.PubMed/NCBI View Article : Google Scholar

Warfel NA and El-Deiry WS: p21WAF1 and tumourigenesis: 20 Years after. Curr Opin Oncol. 25:52–58. 2013.PubMed/NCBI View Article : Google Scholar

Guan Z, Chen J, Li X and Dong N: Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 40(BSR20201807)2020.PubMed/NCBI View Article : Google Scholar

Li Z, Zhang Y, Zhou Y, Wang F, Yin C, Ding L and Zhang S: Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway. Sci Rep. 11(23681)2021.PubMed/NCBI View Article : Google Scholar

Li J, Wang K, Chen X, Meng H, Song M, Wang Y, Xu X and Bai Y: Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol Biol. 13(4)2012.PubMed/NCBI View Article : Google Scholar

Sun C, Su S, Zhu Y, Guo J, Guo S, Qian D, Yu L, Gu W and Duan JA: Salvia miltiorrhiza stem-leaf active components of salvianolic acids and flavonoids improved the hemorheological disorder and vascular endothelial function on microcirculation dysfunction rats. Phytother Res. 34:1704–1720. 2020.PubMed/NCBI View Article : Google Scholar

Li HY, Li Y, Yan CH, Li LN and Chen XG: Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. J Asian Nat Prod Res. 4:271–280. 2002.PubMed/NCBI View Article : Google Scholar

Chen XG, Li Y, Yan CH, Li LN and Han R: Cancer chemopreventive activities of S-3-1, a synthetic derivative of danshinone. J Asian Nat Prod Res. 3:63–75. 2001.PubMed/NCBI View Article : Google Scholar

Qi P, Li Y, Liu X, Jafari FA, Zhang X, Sun Q and Ma Z: Cryptotanshinone suppresses non-small cell lung cancer via microRNA-146a-5p/EGFR axis. Int J Biol Sci. 15:1072–1079. 2019.PubMed/NCBI View Article : Google Scholar

Bi L, Chen J, Yuan X, Jiang Z and Chen W: Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells. Biomed Rep. 1:213–217. 2013.PubMed/NCBI View Article : Google Scholar

Shi H, Zhang Q, Li H, Chu T, Jin H and Mao S: Growth inhibition of tanshinones on SPC-A-1 cell line and their structure-activity relationship. Zhongguo Fei Ai Za Zhi. 14:7–12. 2011.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Miyazaki T and Arai S: Two distinct controls of mitotic cdk1/cyclin B1 activity requisite for cell growth prior to cell division. Cell Cycle. 6:1419–1425. 2007.PubMed/NCBI

Zhang J, Wen G, Sun L, Yuan W, Wang R, Zeng Q, Zhang G and Yu B: Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway. Oncol Rep. 40:2926–2934. 2018.PubMed/NCBI View Article : Google Scholar

Chen Y, Li H, Li M, Niu S, Wang J, Shao H, Li T and Wang H: Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated-MAPK and-NF-κB signaling pathways. J Ethnopharmacol. 200:165–173. 2017.PubMed/NCBI View Article : Google Scholar

Bandi N and Vassella E: miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer. 10(55)2011.PubMed/NCBI View Article : Google Scholar

Shi Y, Liu C, Liu X, Tang DG and Wang J: The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS One. 9(e90022)2014.PubMed/NCBI View Article : Google Scholar

Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, van Mil A, Park WJ, Sluijter JP, Doevendans PA, et al: Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature. 508:531–535. 2014.PubMed/NCBI View Article : Google Scholar

Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, et al: VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med. 10:262–267. 2004.PubMed/NCBI View Article : Google Scholar

Dar AA, Goff LW, Majid S, Berlin J and El-Rifai W: Aurora kinase inhibitors-rising stars in cancer therapeutics? Mol Cancer Ther. 9:268–278. 2010.PubMed/NCBI View Article : Google Scholar

Görgün G, Calabrese E, Hideshima T, Ecsedy J, Perrone G, Mani M, Ikeda H, Bianchi G, Hu Y, Cirstea D, et al: A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. Blood. 115:5202–5213. 2010.PubMed/NCBI View Article : Google Scholar

Hannak E, Kirkham M, Hyman AA and Oegema K: Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J Cell Biol. 155:1109–1116. 2001.PubMed/NCBI View Article : Google Scholar

Marumoto T, Zhang D and Saya H: Aurora-A-a guardian of poles. Nat Rev Cancer. 5:42–50. 2005.PubMed/NCBI View Article : Google Scholar

Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, Hatakeyama K and Saya H: Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell. 114:585–598. 2003.PubMed/NCBI View Article : Google Scholar

Lentini L, Amato A, Schillaci T, Insalaco L and Di Leonardo A: Aurora-A transcriptional silencing and vincristine treatment show a synergistic effect in human tumor cells. Oncol Res. 17:115–125. 2008.PubMed/NCBI View Article : Google Scholar

Kaestner P, Stolz A and Bastians H: Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells. Mol Cancer Ther. 8:2046–2056. 2009.PubMed/NCBI View Article : Google Scholar

Compérat E, Bièche I, Dargère D, Laurendeau I, Vieillefond A, Benoit G, Vidaud M, Camparo P, Capron F, Verret C, et al: Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. Urology. 72:873–877. 2008.PubMed/NCBI View Article : Google Scholar

Lee ECY, Frolov A, Li R, Ayala G and Greenberg NM: Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res. 66:4996–5002. 2006.PubMed/NCBI View Article : Google Scholar

Matarasso N, Bar-Shira A, Rozovski U, Rosner S and Orr-Urtreger A: Functional analysis of the Aurora kinase A Ile31 allelic variant in human prostate. Neoplasia. 9:707–715. 2007.PubMed/NCBI View Article : Google Scholar

Kumano M, Miyake H, Terakawa T, Furukawa J and Fujisawa M: Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model. BJU Int. 106:121–127. 2010.PubMed/NCBI View Article : Google Scholar

Addepalli MK, Ray KB, Kumar B, Ramnath RL, Chile S and Rao H: RNAi-mediated knockdown of AURKB and EGFR shows enhanced therapeutic efficacy in prostate tumor regression. Gene Ther. 17:352–359. 2010.PubMed/NCBI View Article : Google Scholar

Li Y, Zhang ZF, Chen J, Huang D, Ding Y, Tan MH, Qian CN, Resau JH, Kim H and The BT: VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res. 2:296–308. 2010.PubMed/NCBI

Wang X, Dong L, Xie J, Tong T and Zhan Q: Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther. 8:1852–1859. 2009.PubMed/NCBI View Article : Google Scholar

Pérez de Castro I, de Cárcer G, Montoya G and Malumbres M: Emerging cancer therapeutic opportunities by inhibiting mitotic kinases. Curr Opin Pharmacol. 8:375–383. 2008.PubMed/NCBI View Article : Google Scholar

Tung YT, Chen HL, Lee CY, Chou YC, Lee PY, Tsai HC, Lin YL and Chen CM: Active component of Danshen (Salvia miltiorrhiza Bunge), tanshinone I, attenuates lung tumorigenesis via inhibitions of VEGF, cyclin A, and cyclin B expressions. Evid Based Complement Alternat Med. 2013(319247)2013.PubMed/NCBI View Article : Google Scholar

Tian H, Li Y, Mei J, Cao L, Yin J, Liu Z, Chen J and Li X: Effects of Salvia miltiorrhiza extract on lung adenocarcinoma. Exp Ther Med. 22(794)2021.PubMed/NCBI View Article : Google Scholar

Gao F, Li M, Liu W and Li W: Inhibition of EGFR signaling and activation of mitochondrial apoptosis contribute to tanshinone IIA-mediated tumor suppression in non-small cell lung cancer cells. OncoTargets Ther. 13:2757–2769. 2020.PubMed/NCBI View Article : Google Scholar

Wang M, Tang W, Gong N and Liu P: Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathway. Drug Dev Res. 83:88–96. 2022.PubMed/NCBI View Article : Google Scholar

Lu Z, Zhou R, Kong Y, Wang J, Xia W, Guo J, Liu J, Sun H, Liu K, Yang J, et al: S-equol, a secondary metabolite of natural anticancer isoflavone daidzein, inhibits prostate cancer growth in vitro and in vivo, though activating the Akt/FOXO3a pathway. Curr Cancer Drug Targets. 16:455–465. 2016.PubMed/NCBI View Article : Google Scholar

Li Q, Hu K, Tang S, Xu LF and Luo YC: Anti-tumor activity of tanshinone IIA in combined with cyclophosphamide against Lewis mice with lung cancer. Asian Pac J Trop Med. 9:1084–1088. 2016.PubMed/NCBI View Article : Google Scholar

Bi L, Yan X, Yang Y, Qian L, Tian Y, Mao JH and Chen W: The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells. Oncotarget. 8:101599–101613. 2017.PubMed/NCBI View Article : Google Scholar

Yan XJ, Yang Y, Bi L, Chen SS, Zhu JJ and Chen WP: Effects of component formula of Salviae miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma on cell proliferation, apoptosis and skeleton in lung cancer A549 cells. Zhongguo Zhong Yao Za Zhi. 39:4436–4441. 2014.PubMed/NCBI(In Chinese).

Zinnah KMA and Park SY: Sensitizing TRAIL-resistant A549 lung cancer cells and enhancing TRAIL-induced apoptosis with the antidepressant amitriptyline. Oncol Rep. 46(144)2021.PubMed/NCBI View Article : Google Scholar

He J, Zhou Q, Yuan S, Wang Y, Chen X and Qin J: The growth-inhibiting effect and its molecular mechanism of Tanshinone on human lung cancer cell line in vitro. Zhongguo Fei Ai Za Zhi. 5:123–125. 2002.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Hu H, Zhang Y, Huang F and Deng H: Inhibition of proliferation and induction of apoptosis by tanshinone II A in NCI-H460 cell. Zhong Yao Cai. 28:301–304. 2005.PubMed/NCBI(In Chinese).

Liu F, Yu G, Wang G, Liu H, Wu X, Wang Q, Liu M, Liao K, Wu M, Cheng X and Hao H: An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer. PLoS One. 7(e42138)2012.PubMed/NCBI View Article : Google Scholar

Zhang J, Wang J, Jiang JY, Liu SD, Fu K and Liu HY: Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway. Int J Oncol. 45:683–690. 2014.PubMed/NCBI View Article : Google Scholar

Kim EO, Kang SE, Im CR, Lee JH, Ahn KS, Yang WM, Um JY, Lee SG and Yun M: Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction. Int J Oncol. 48:2205–2212. 2016.PubMed/NCBI View Article : Google Scholar

Liu HY, Li QR, Cheng XF, Wang GJ and Hao HP: NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells. Chin J Nat Med. 14:582–589. 2016.PubMed/NCBI View Article : Google Scholar

Israels LG and Israels ED: Apoptosis. Oncologist. 4:332–339. 1999.PubMed/NCBI

Xu X, Lai Y and Hua ZC: Apoptosis and apoptotic body: Disease message and therapeutic target potentials. Biosci Rep. 39(BSR20180992)2019.PubMed/NCBI View Article : Google Scholar

Pistritto G, Trisciuoglio D, Ceci C, Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 8:603–619. 2016.PubMed/NCBI View Article : Google Scholar

Wu GS: TRAIL as a target in anti-cancer therapy. Cancer Lett. 285:1–5. 2009.PubMed/NCBI View Article : Google Scholar

Chang CC, Lai JS, Tsai CS, Ma SW, Lin JY, Huang LR, Lu CH, Liao EC and Ho TF: Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen). J Biosci Bioeng. 116:516–523. 2013.PubMed/NCBI View Article : Google Scholar

Shen L, Lou Z and Zhang G, Xu G and Zhang G: Diterpenoid tanshinones, the extract from Danshen (Radix Salviae miltiorrhizae) induced apoptosis in nine human cancer cell lines. J Tradit Chin Med. 36:514–521. 2016.PubMed/NCBI View Article : Google Scholar

Lou ZH, Xia RM, Li XJ, Cheng RB, Shao KD and Zhang GJ: Anti-lung cancer mechanisms of diterpenoid tanshinone via endoplasmic reticulum stress-mediated apoptosis signal pathway. Zhongguo Zhong Yao Za Zhi. 43:4900–4907. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Xie J, Liu J, Liu H, Liang S, Lin M, Gu Y, Liu T, Wang D, Ge H and Mo SL: The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line. Acta Pharm Sin B. 5:554–563. 2015.PubMed/NCBI View Article : Google Scholar

Chen D, Lin XX, Huang WH, Zhang W, Tan ZR, Peng JB, Wang YC, Guo Y, Hu DL and Chen Y: Sodium tanshinone IIA sulfonate and its interactions with human CYP450s. Xenobiotica. 46:1085–1092. 2016.PubMed/NCBI View Article : Google Scholar

Zhou X, Pan Y, Wang Y, Wang B, Yan Y, Qu Y and Ke X: Tanshinones induce tumor cell apoptosis via directly targeting FHIT. Sci Rep. 11(12217)2021.PubMed/NCBI View Article : Google Scholar

Wu CY, Yang YH, Lin YS, Chang GH, Tsai MS, Hsu CM, Yeh RA, Shu LH, Cheng YC and Liu HT: Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomed Pharmacother. 139(111585)2021.PubMed/NCBI View Article : Google Scholar

Singh R and Cuervo AM: Autophagy in the cellular energetic balance. Cell Metab. 13:495–504. 2011.PubMed/NCBI View Article : Google Scholar

Sridhar S, Botbol Y, Macian F and Cuervo AM: Autophagy and disease: Always two sides to a problem. J Pathol. 226:255–273. 2012.PubMed/NCBI View Article : Google Scholar

Fukuda K, Kobayashi A and Watabe K: The role of tumor-associated macrophage in tumor progression. Front Biosci (Schol Ed). 4:787–798. 2012.PubMed/NCBI View Article : Google Scholar

Li GG, Guo ZZ, Ma XF, Cao N, Geng SN, Zheng YQ, Meng MJ, Lin HH, Han G and Du GJ: The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis. Dev Comp Immunol. 59:89–98. 2016.PubMed/NCBI View Article : Google Scholar

Hao W, Zhang X, Zhao W, Zhu H, Liu ZY, Lu J and Chen X: Cryptotanshinone induces pro-death autophagy through JNK signaling mediated by reactive oxygen species generation in lung cancer cells. Anticancer Agents Med Chem. 16:593–600. 2016.PubMed/NCBI View Article : Google Scholar

Guo S, Luo W, Liu L, Pang X, Zhu H, Liu A, Lu J, Ma DL, Leung CH, Wang Y and Chen X: Isocryptotanshinone, a STAT3 inhibitor, induces apoptosis and pro-death autophagy in A549 lung cancer cells. J Drug Target. 24:934–942. 2016.PubMed/NCBI View Article : Google Scholar

Zhang B, Ma Z, Li X, Zhang C, Shao Y, Liu Z, Li Y and Jin Y: Tanshinones suppress non-small cell lung cancer through up-regulating miR-137. Acta Biochim Biophys Sin (Shanghai). 48:768–770. 2016.PubMed/NCBI View Article : Google Scholar

Gao H, Sun W, Zhao W, Hao W, Leung CH, Lu J and Chen X: Total tanshinones-induced apoptosis and autophagy via reactive oxygen species in lung cancer 95D cells. Am J Chin Med. 43:1265–1279. 2015.PubMed/NCBI View Article : Google Scholar

Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, Liu YC, Hong TH, Yu SL, Chen JJ and Yang PC: Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep. 5(14273)2015.PubMed/NCBI View Article : Google Scholar

Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004.PubMed/NCBI View Article : Google Scholar

Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R and Schwartz CJ: Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 27:4162–4168. 1988.PubMed/NCBI View Article : Google Scholar

Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J and Leonard EJ: Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 169:1449–1459. 1989.PubMed/NCBI View Article : Google Scholar

Schmall A, Al-Tamari HM, Herold S, Kampschulte M, Weigert A, Wietelmann A, Vipotnik N, Grimminger F, Seeger W, Pullamsetti SS and Savai R: Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am J Respir Crit Care Med. 191:437–447. 2015.PubMed/NCBI View Article : Google Scholar

Man Y, Yang L, Zhang D and Bi Y: Cryptotanshinone inhibits lung tumor growth by increasing CD4⁺ T cell cytotoxicity through activation of the JAK2/STAT4 pathway. Oncol Lett. 12:4094–4098. 2016.PubMed/NCBI View Article : Google Scholar

Liu S, Han Z, Trivett AL, Lin H, Hannifin S, Yang D and Oppenheim JJ: Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. Cancer Immunol Immunother. 68:1059–1071. 2019.PubMed/NCBI View Article : Google Scholar

Wu CY, Cherng JY, Yang YH, Lin CL, Kuan FC, Lin YY, Lin YS, Shu LH, Cheng YC, Liu HT, et al: Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells. Oncotarget. 8:90925–90947. 2017.PubMed/NCBI View Article : Google Scholar

Lee CY, Sher HF, Chen HW, Liu CC, Chen CH, Lin CS, Yang PC, Tsay HS and Chen JJ: Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol Cancer Ther. 7:3527–3538. 2008.PubMed/NCBI View Article : Google Scholar

Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R and Wu CW: Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol. 17:353–360. 1997.PubMed/NCBI View Article : Google Scholar

Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW and Yang PC: Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61:5223–5230. 2001.PubMed/NCBI

Carmeliet P and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature. 473:298–307. 2011.PubMed/NCBI View Article : Google Scholar

Tammela T, Enholm B, Alitalo K and Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res. 65:550–563. 2005.PubMed/NCBI View Article : Google Scholar

Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.PubMed/NCBI View Article : Google Scholar

Jin L, Chen C, Huang L, Bu L, Zhang L and Yang Q: Salvianolic acid A blocks vasculogenic mimicry formation in human non-small cell lung cancer via PI3K/Akt/mTOR signalling. Clin Exp Pharmacol Physiol. 48:508–514. 2021.PubMed/NCBI View Article : Google Scholar

Zhang Y, Wang L, Chen Y and Qing C: Anti-angiogenic activity of salvicine. Pharm Biol. 51:1061–1065. 2013.PubMed/NCBI View Article : Google Scholar

Zhang P, Pei Y and Qi Y: Influence of blood-activating drugs on adhesion and invasion of cells in lung cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 19:103–105. 1999.PubMed/NCBI(In Chinese).

Wang H, Zhang Y, Zhang Y, Liu W and Wang J: Cryptotanshinone inhibits lung cancer invasion via microRNA-133a/matrix metalloproteinase 14 regulation. Oncol Lett. 18:2554–2559. 2019.PubMed/NCBI View Article : Google Scholar

Xie J, Liu JH, Liu H, Liao XZ, Chen Y, Lin MG, Gu YY, Liu TL, Wang DM, Ge H and Mo SL: Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. BMC Cancer. 16(899)2016.PubMed/NCBI View Article : Google Scholar

Zhang XZ, Qian SS, Zhang YJ and Wang RQ: Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs. Pharm Biol. 54:18–24. 2016.PubMed/NCBI View Article : Google Scholar

He SB, Zhang BX, Wang HH, Wang Y and Qiao YJ: Study on mechanism of Salvia miltiorrhiza treating cardiovascular disease through auxiliary mechanism elucidation system for Chinese medicine. Zhongguo Zhong Yao Za Zhi. 40:3713–3717. 2015.PubMed/NCBI(In Chinese).

Chuang MT, Ho FM, Wu CC, Zhuang SY, Lin SY, Suk FM and Liang YC: 15,16-Dihydrotanshinone I, a compound of Salvia miltiorrhiza bunge, induces apoptosis through inducing endoplasmic reticular stress in human prostate carcinoma cells. Evid Based Complement Alternat Med. 2011(865435)2011.PubMed/NCBI View Article : Google Scholar

Chen FY, Bi L, Qian L, Gao J, Jiang YC and Chen WP: Identification of multidrug resistance gene MDR1 associated microRNA of salvianolic acid A reversal in lung cancer. Zhongguo Zhong Yao Za Zhi. 41:3279–3284. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Tang XL, Yan L, Zhu L, Jiao DM, Chen J and Chen QY: Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway. J Pharmacol Sci. 135:1–7. 2017.PubMed/NCBI View Article : Google Scholar

Xia C, Bai X, Hou X, Gou X, Wang Y, Zeng H, Huang M and Jin J: Cryptotanshinone reverses cisplatin resistance of human lung carcinoma A549 cells through down-regulating Nrf2 pathway. Cell Physiol Biochem. 37:816–824. 2015.PubMed/NCBI View Article : Google Scholar

Jiang Y, You F, Zhu J, Zheng C, Yan R and Zeng J: Cryptotanshinone ameliorates radiation-induced lung injury in rats. Evid Based Complement Alternat Med. 2019(1908416)2019.PubMed/NCBI View Article : Google Scholar

Liao XZ, Gao Y, Huang S, Chen ZZ, Sun LL, Liu JH, Chen HR, Yu L, Zhang JX and Lin LZ: Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway. Phytother Res. 33:2298–2309. 2019.PubMed/NCBI View Article : Google Scholar

Wang R, Luo Z, Zhang H and Wang T: Tanshinone IIA reverses gefitinib-resistance in human non-small-cell lung cancer via regulation of VEGFR/Akt pathway. Onco Targets Ther. 12:9355–9365. 2019.PubMed/NCBI View Article : Google Scholar

Cao HY, Ding RL, Li M, Yang MN, Yang LL, Wu JB, Yang B, Wang J, Luo CL and Wen QL: Danshensu, a major water-soluble component of Salvia miltiorrhiza, enhances the radioresponse for Lewis lung carcinoma xenografts in mice. Oncol Lett. 13:605–612. 2017.PubMed/NCBI View Article : Google Scholar

Kim JH, Jeong SJ, Kwon TR, Yun SM, Jung JH, Kim M, Lee HJ, Lee MH, Ko SG, Chen CY and Kim SH: Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells. Apoptosis. 16:696–707. 2011.PubMed/NCBI View Article : Google Scholar

Su CC: Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med. 3:555–559. 2012.PubMed/NCBI View Article : Google Scholar

Ye Y, Xu W, Zhong W, Li Y and Wang C: Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation. Mol Cell Biochem. 363:191–202. 2012.PubMed/NCBI View Article : Google Scholar

Xia R and Chen X: Effects of Danshen injection on the malignant obstructive jaundice in the SD rat model. J Huazhong Univ Sci Technolog Med Sci. 26:686–689. 2006.PubMed/NCBI View Article : Google Scholar

Wang T, Fu X and Wang Z: Danshen Formulae for Cancer: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. Evid Based Complement Altern Med. 2019(2310639)2019.PubMed/NCBI View Article : Google Scholar

Yang Y, Qiu S, Qian L, Tian Y, Chen Y, Bi L and Chen W: OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells. PLoS One. 12(e0174021)2017.PubMed/NCBI View Article : Google Scholar

Geng QX, Zhu XL and Zhang XH: Effect of combined therapy of shenmai and compound danshen injection on myocardial reperfusion injury after percutaneous coronary intervention in patients with acute myocardial infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi. 24:496–499. 2004.PubMed/NCBI(In Chinese).

Zhang X, Luo W, Zhao W, Lu J and Chen X: Isocryptotanshinone induced apoptosis and activated MAPK signaling in human breast cancer MCF-7 cells. J Breast Cancer. 18:112–118. 2015.PubMed/NCBI View Article : Google Scholar

Di Cesare Mannelli L, Piccolo M, Maione F, Ferraro MG, Irace C, De Feo V, Ghelardini C and Mascolo N: Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed Pharmacother. 105:1042–1049. 2018.PubMed/NCBI View Article : Google Scholar

Shen YD, Tian YX, Bu XZ and Gu LQ: Natural tanshinone-like heterocyclic-fused ortho-quinones from regioselective Diels-Alder reaction: Synthesis and cytotoxicity evaluation. Eur J Med Chem. 44:3915–3921. 2009.PubMed/NCBI View Article : Google Scholar